Chizl’ – Developed for Individuals Seeking Fast & Effective Pain Relief On-the-Go

The Chizl, (handheld) was developed for those seeking fast and effective pain relief on-the-go. The Chizl offers users full control of their manual treatment without the hassle of cords, batteries, setup, and noise.

The launch follows the official release of Mobility Wall’s game-changing vertical foam roller collection in September 2021, including Mobility Wall Smooth Roller and Mobility Wall Pro Series.

“Mobility Wall’s vertical roller collection was created with every kind of user in mind,” says Mobility Wall Inventor & Co-Founder, Chris DiVecchio. “With faster and more effective pain relief for the whole body being our main focus, it only made sense to develop a product that allows users to improve mobility and achieve relief whenever and wherever they need it the most.”

Featuring unmatched portability, The Chizl provides the benefits of Mobility Wall’s Smooth Roller and Pro Series in a compact yet powerful, sleek design.

The handheld product’s attachments include “The Wedge,” to improve blood flow and neurological connectivity using short and long tissue glides, “The Thumb,” a small, smooth, and incredibly strong tool made to dig into knots, and “The Cone,” which uses a fine point tip to reach areas like the hands and feet as well as separate muscle fibers that often get stuck together like the quads and calves.

The Chizl retails for $49 ($39 when pre-ordering). To pre-order The Chizl, which is expected to ship early 2022 visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”